NFKB1 and liver cancer: It decreased the levels of liver dysfunction biomarkers (SGPT and SGOT), lipid peroxidation (LPO), and stimulated SIRT1 to inhibit NF-κB, thereby increasing the sensitivity of liver cancer cells to TNF-α-induced apoptosis (Rawat et al., 2021).